Difficulty: Medium
Average Score: 87%
Practice
A 35-year-old woman with a history of world travel is found to have a hookworm infection. She has begun on therapy with mebendazole therapy orally and now returns home for follow-up. Which of the following statements regarding the pharmacodynamics of this agent is correct?
Correct answer
B
Rationale
The correct answer is B) Hepatic first-pass metabolism is achieved.
Explanation:
Mebendazole undergoes hepatic first-pass metabolism, meaning it is metabolized in the liver before reaching systemic circulation. This process can affect the drug's bioavailability and overall effectiveness. Understanding this pharmacodynamic characteristic is crucial in determining the drug's dosing regimen and potential interactions with other medications that may affect liver function.
Why the other options are wrong:
A) Best results are obtained with intravenous doses - Mebendazole is typically administered orally for the treatment of parasitic infections, and intravenous administration is not the preferred route for this drug.
C) Low-fat meals enhance absorption - Mebendazole absorption is not significantly influenced by food intake, whether it is taken with or without meals.
D) Side effect profile is unfavorable - Mebendazole is generally well-tolerated, with common side effects being mild and transient, such as gastrointestinal symptoms. It is considered a safe and effective treatment for parasitic infections.
Educational context:
Understanding the pharmacodynamics of chemotherapy drugs like mebendazole is essential for healthcare professionals to ensure proper dosing, monitor for potential interactions, and optimize therapeutic outcomes for patients. By grasping the drug's metabolism pathway, healthcare providers can make informed decisions regarding treatment strategies and patient care.
Explanation:
Mebendazole undergoes hepatic first-pass metabolism, meaning it is metabolized in the liver before reaching systemic circulation. This process can affect the drug's bioavailability and overall effectiveness. Understanding this pharmacodynamic characteristic is crucial in determining the drug's dosing regimen and potential interactions with other medications that may affect liver function.
Why the other options are wrong:
A) Best results are obtained with intravenous doses - Mebendazole is typically administered orally for the treatment of parasitic infections, and intravenous administration is not the preferred route for this drug.
C) Low-fat meals enhance absorption - Mebendazole absorption is not significantly influenced by food intake, whether it is taken with or without meals.
D) Side effect profile is unfavorable - Mebendazole is generally well-tolerated, with common side effects being mild and transient, such as gastrointestinal symptoms. It is considered a safe and effective treatment for parasitic infections.
Educational context:
Understanding the pharmacodynamics of chemotherapy drugs like mebendazole is essential for healthcare professionals to ensure proper dosing, monitor for potential interactions, and optimize therapeutic outcomes for patients. By grasping the drug's metabolism pathway, healthcare providers can make informed decisions regarding treatment strategies and patient care.